Suppression of cancer metastasis

Details for Australian Patent Application No. 2010321830 (hide)

Owner Academia Sinica

Inventors Liang, Shu-Mei; Chiu, Ching-Feng; Hung, Shao-Wen; Peng, Jei-Ming; Liang, Chi-Ming

Agent Spruson & Ferguson

Pub. Number AU-A-2010321830

PCT Pub. Number WO2011/063275

Priority 61/281,917 23.11.09 US; 12/623,162 20.11.09 US

Filing date 19 November 2010

Wipo publication date 26 May 2011

International Classifications

C07K 14/76 Peptides having more than 20 amino acids

A61K 38/38 Medicinal preparations containing peptides - Albumins

A61K 47/48 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

5 July 2012 PCT application entered the National Phase

  PCT publication WO2011/063275 Priority application(s): WO2011/063275

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010321831-7-[3,5-dihydroxy-2- (3-hydroxy-5-phenyl-pent-1-enyl)- cyclopentyl]-N-ethyl-hept-5-enamide (bimatoprost) in crystalline form II, methods for preparation, and methods for use thereof

2010321829-Methods to predict clinical outcome of cancer